After DKA Warning, Avoid SGLT2-Inhibitor Use in Type 1 DiabetesAfter DKA Warning, Avoid SGLT2-Inhibitor Use in Type 1 Diabetes

A case series finds 13 episodes of euglycemic diabetic ketoacidosis associated with SGLT2-inhibitor use in both types of diabetes; the authors advise avoiding these agents in those with type 1 diabetes. Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news